$XLRN Recent News IPO scorecard: Rocket Fuel,
Post# of 94144
Posted On: 01/11/2015 1:18:49 PM
$XLRN Recent News
IPO scorecard: Rocket Fuel, FireEye, Benefitfocus 3:05 p.m. Sept. 24, 2013 - MarketWatch.com
Minerva Neurosciences' MIN-301 Positive in Primate Study - Analyst Blog 7:20 p.m. Jan. 6, 2015 - Zacks.com
InsiderInsights.com Daily Round Up 12/29/14: REGN, VRML, OAS, PTBI 1:23 p.m. Dec. 30, 2014 - Seeking Alpha
Commit To Purchase Acceleron Pharma At $30, Earn 16.7% Annualized Using Options 12:20 p.m. Dec. 24, 2014 - TheStreet.com
Nasdaq makes annual changes to Biotechnology Index 12:36 p.m. Dec. 15, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 12/10/14: PSEC, TWI, SGEN, ATLS 1:18 a.m. Dec. 11, 2014 - Seeking Alpha
Acceleron Pharma, Inc. (XLRN) in Focus: Stock Soars 13.6% - Tale of the Tape 9:21 a.m. Dec. 9, 2014 - Zacks.com
Encouraging results for luspatercept in Phase 2 11:51 a.m. Dec. 8, 2014 - Seeking Alpha
Acceleron Pharma (XLRN) Strong On High Relative Volume Today 10:02 a.m. Dec. 8, 2014 - TheStreet.com
The 7 Most Important Drug-Stock Lessons From This Weekend's Blood Cancer Meeting 7:15 a.m. Dec. 8, 2014 - TheStreet.com
Acceleron Drugs Reduce Anemia Caused by Rare Blood Disorders 3:33 p.m. Dec. 7, 2014 - TheStreet.com
Will Acceleron (XLRN) Continue to Surge Higher? - Tale of the Tape 9:24 a.m. Dec. 1, 2014 - Zacks.com
Acceleron Pharma's (XLRN) CEO John Knopf on Q3 2014 Results - Earnings Call Transcript 7:29 a.m. Nov. 8, 2014 - Seeking Alpha
10-Q: ACCELERON PHARMA INC 9:31 a.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Acceleron Pharma Is Due For A Market Correction And Is An Attractive Short Candidate During The Coming Months 7:59 a.m. Oct. 31, 2014 - Seeking Alpha
Acceleron Hit Over Competitive Concerns, But Investors Overlook Rest of Pipeline 8:21 a.m. Oct. 2, 2014 - TheStreet.com
Ocera Therapeutics Finally Ready To Reward Investors 11:32 a.m. Oct. 1, 2014 - Seeking Alpha
Will Acceleron (XLRN) Continue to Surge Higher? - Tale of the Tape 7:56 a.m. Oct. 1, 2014 - Zacks.com
9 Biotechnology Stocks to Buy Now 5:00 a.m. Oct. 1, 2014 - InvestorPlace.com
Acceleron Pharma (XLRN) Jumps: Stock Rises 12.8% - Tale of the Tape 8:39 a.m. Sept. 24, 2014 - Zacks.com
Acceleron ovarian cancer candidate comes up short in clinical trial 9:06 a.m. Sept. 23, 2014 - Seeking Alpha
Adimab Announces New Partnerships with Acceleron, Oncothyreon, Surface Oncology and Potenza 9:45 a.m. Jan. 9, 2015 - BusinessWire - BZX
Vericel Corporation Names Three New Board Members 8:46 a.m. Jan. 7, 2015 - Marketwired
Acceleron Pharma Added to NASDAQ Biotechnology Index 8:02 a.m. Dec. 15, 2014 - BusinessWire - BZX
Annual Changes to the NASDAQ Biotechnology Index 7:10 a.m. Dec. 15, 2014 - GlobeNewswire
Acceleron Pharma Appoints Dr. Francois Nader to its Board of Directors 7:30 a.m. Dec. 12, 2014 - BusinessWire - BZX
Luspatercept Data on Myelodysplastic Syndromes Selected for “Best of ASH” by the American Society of Hematology 7:30 a.m. Dec. 10, 2014 - BusinessWire - BZX
New Data in Myelodysplastic Syndromes Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition 2:00 p.m. Dec. 8, 2014 - BusinessWire - BZX
Acceleron Pharma to Present at Upcoming Investor Conferences in December 7:31 a.m. Nov. 24, 2014 - BusinessWire - BZX
Acceleron Pharma Reports Third Quarter 2014 Financial and Operational Results 7:31 a.m. Nov. 7, 2014 - BusinessWire - BZX
Acceleron Announces New Clinical Data Presentations at the 2014 American Society of Hematology Annual Meeting 9:32 a.m. Nov. 6, 2014 - BusinessWire - BZX
Acceleron Pharma to Host Third Quarter 2014 Financial Results Conference Call and Webcast on November 7, 2014 6:30 a.m. Oct. 30, 2014 - BusinessWire - BZX
Acceleron Pharma to Present at Upcoming Investor Conferences in November 6:31 a.m. Oct. 29, 2014 - BusinessWire - BZX
Acceleron Collaboration Partner Celgene to Present Data at the American Society of Nephrology Kidney Week 2014 9:52 a.m. Oct. 23, 2014 - BusinessWire - BZX
Acceleron Announces Educational Webcast on Chronic Kidney Disease - Mineral and Bone Disorder 6:31 a.m. Oct. 22, 2014 - BusinessWire - BZX
Acceleron Initiates Phase 1 Clinical Trial with Innovative Muscle Drug ACE-083 6:31 a.m. Oct. 14, 2014 - BusinessWire - BZX
Acceleron to Host Educational Webcast on Beta-thalassemia 6:30 a.m. Oct. 1, 2014 - BusinessWire - BZX
Acceleron to Webcast Presentation at Leerink Partners Rare Disease Roundtable 6:30 a.m. Sept. 29, 2014 - BusinessWire - BZX
Acceleron Provides Update on Externally Sponsored Clinical Trial of Dalantercept Monotherapy in Ovarian Cancer 7:30 a.m. Sept. 23, 2014 - BusinessWire - BZX
Acceleron to Host Educational Webcast Series with Clinical Thought Leaders 6:01 a.m. Sept. 16, 2014 - BusinessWire - BZX
Acceleron Pharma to Present at Upcoming Investor Conferences in September 6:00 a.m. Aug. 27, 2014 - BusinessWire - BZX
IPO scorecard: Rocket Fuel, FireEye, Benefitfocus 3:05 p.m. Sept. 24, 2013 - MarketWatch.com
Minerva Neurosciences' MIN-301 Positive in Primate Study - Analyst Blog 7:20 p.m. Jan. 6, 2015 - Zacks.com
InsiderInsights.com Daily Round Up 12/29/14: REGN, VRML, OAS, PTBI 1:23 p.m. Dec. 30, 2014 - Seeking Alpha
Commit To Purchase Acceleron Pharma At $30, Earn 16.7% Annualized Using Options 12:20 p.m. Dec. 24, 2014 - TheStreet.com
Nasdaq makes annual changes to Biotechnology Index 12:36 p.m. Dec. 15, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 12/10/14: PSEC, TWI, SGEN, ATLS 1:18 a.m. Dec. 11, 2014 - Seeking Alpha
Acceleron Pharma, Inc. (XLRN) in Focus: Stock Soars 13.6% - Tale of the Tape 9:21 a.m. Dec. 9, 2014 - Zacks.com
Encouraging results for luspatercept in Phase 2 11:51 a.m. Dec. 8, 2014 - Seeking Alpha
Acceleron Pharma (XLRN) Strong On High Relative Volume Today 10:02 a.m. Dec. 8, 2014 - TheStreet.com
The 7 Most Important Drug-Stock Lessons From This Weekend's Blood Cancer Meeting 7:15 a.m. Dec. 8, 2014 - TheStreet.com
Acceleron Drugs Reduce Anemia Caused by Rare Blood Disorders 3:33 p.m. Dec. 7, 2014 - TheStreet.com
Will Acceleron (XLRN) Continue to Surge Higher? - Tale of the Tape 9:24 a.m. Dec. 1, 2014 - Zacks.com
Acceleron Pharma's (XLRN) CEO John Knopf on Q3 2014 Results - Earnings Call Transcript 7:29 a.m. Nov. 8, 2014 - Seeking Alpha
10-Q: ACCELERON PHARMA INC 9:31 a.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Acceleron Pharma Is Due For A Market Correction And Is An Attractive Short Candidate During The Coming Months 7:59 a.m. Oct. 31, 2014 - Seeking Alpha
Acceleron Hit Over Competitive Concerns, But Investors Overlook Rest of Pipeline 8:21 a.m. Oct. 2, 2014 - TheStreet.com
Ocera Therapeutics Finally Ready To Reward Investors 11:32 a.m. Oct. 1, 2014 - Seeking Alpha
Will Acceleron (XLRN) Continue to Surge Higher? - Tale of the Tape 7:56 a.m. Oct. 1, 2014 - Zacks.com
9 Biotechnology Stocks to Buy Now 5:00 a.m. Oct. 1, 2014 - InvestorPlace.com
Acceleron Pharma (XLRN) Jumps: Stock Rises 12.8% - Tale of the Tape 8:39 a.m. Sept. 24, 2014 - Zacks.com
Acceleron ovarian cancer candidate comes up short in clinical trial 9:06 a.m. Sept. 23, 2014 - Seeking Alpha
Adimab Announces New Partnerships with Acceleron, Oncothyreon, Surface Oncology and Potenza 9:45 a.m. Jan. 9, 2015 - BusinessWire - BZX
Vericel Corporation Names Three New Board Members 8:46 a.m. Jan. 7, 2015 - Marketwired
Acceleron Pharma Added to NASDAQ Biotechnology Index 8:02 a.m. Dec. 15, 2014 - BusinessWire - BZX
Annual Changes to the NASDAQ Biotechnology Index 7:10 a.m. Dec. 15, 2014 - GlobeNewswire
Acceleron Pharma Appoints Dr. Francois Nader to its Board of Directors 7:30 a.m. Dec. 12, 2014 - BusinessWire - BZX
Luspatercept Data on Myelodysplastic Syndromes Selected for “Best of ASH” by the American Society of Hematology 7:30 a.m. Dec. 10, 2014 - BusinessWire - BZX
New Data in Myelodysplastic Syndromes Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition 2:00 p.m. Dec. 8, 2014 - BusinessWire - BZX
Acceleron Pharma to Present at Upcoming Investor Conferences in December 7:31 a.m. Nov. 24, 2014 - BusinessWire - BZX
Acceleron Pharma Reports Third Quarter 2014 Financial and Operational Results 7:31 a.m. Nov. 7, 2014 - BusinessWire - BZX
Acceleron Announces New Clinical Data Presentations at the 2014 American Society of Hematology Annual Meeting 9:32 a.m. Nov. 6, 2014 - BusinessWire - BZX
Acceleron Pharma to Host Third Quarter 2014 Financial Results Conference Call and Webcast on November 7, 2014 6:30 a.m. Oct. 30, 2014 - BusinessWire - BZX
Acceleron Pharma to Present at Upcoming Investor Conferences in November 6:31 a.m. Oct. 29, 2014 - BusinessWire - BZX
Acceleron Collaboration Partner Celgene to Present Data at the American Society of Nephrology Kidney Week 2014 9:52 a.m. Oct. 23, 2014 - BusinessWire - BZX
Acceleron Announces Educational Webcast on Chronic Kidney Disease - Mineral and Bone Disorder 6:31 a.m. Oct. 22, 2014 - BusinessWire - BZX
Acceleron Initiates Phase 1 Clinical Trial with Innovative Muscle Drug ACE-083 6:31 a.m. Oct. 14, 2014 - BusinessWire - BZX
Acceleron to Host Educational Webcast on Beta-thalassemia 6:30 a.m. Oct. 1, 2014 - BusinessWire - BZX
Acceleron to Webcast Presentation at Leerink Partners Rare Disease Roundtable 6:30 a.m. Sept. 29, 2014 - BusinessWire - BZX
Acceleron Provides Update on Externally Sponsored Clinical Trial of Dalantercept Monotherapy in Ovarian Cancer 7:30 a.m. Sept. 23, 2014 - BusinessWire - BZX
Acceleron to Host Educational Webcast Series with Clinical Thought Leaders 6:01 a.m. Sept. 16, 2014 - BusinessWire - BZX
Acceleron Pharma to Present at Upcoming Investor Conferences in September 6:00 a.m. Aug. 27, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼